| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:48 UTC |
|---|
| HMDB ID | HMDB0014943 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Minaprine |
|---|
| Description | Minaprine, also known as minaprinum or cantor, belongs to the class of organic compounds known as phenylpyridazines. These are organic compounds containing a pyridazine ring substituted by a phenyl group. A study found that it acts as a reversible inhibitor of MAO-A (RIMA) in rats. Minaprine is a drug which is used for the treatment of depression. Minaprine is a very strong basic compound (based on its pKa). Minaprine is a potentially toxic compound. In a study it has also been found to weakly inhibit acetylcholinesterase in rat brain (striatum) homogenates. Minaprine (INN, USAN, BAN) (brand names Brantur, Cantor) is a monoamine oxidase inhibitor antidepressant drug that was used in France for the treatment of depression until it was withdrawn from the market in 1996 because it caused convulsions. |
|---|
| Structure | CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1 InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20) |
|---|
| Synonyms | | Value | Source |
|---|
| 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine | ChEBI | | 4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin | ChEBI | | Minaprina | ChEBI | | Minaprinum | ChEBI | | N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine | ChEBI | | Cantor | Kegg | | 3-(Morpholinoethyl)amino-4-methyl-6-phenylpyridazine | HMDB | | Minaprine dihydrochloride | HMDB | | 3-(2-Morpholino-ethylamino)-4-methyl-6-phenyl pyridazine, dihydrochloride | HMDB | | MINAPRINE hydrochloride | HMDB |
|
|---|
| Chemical Formula | C17H22N4O |
|---|
| Average Molecular Weight | 298.3828 |
|---|
| Monoisotopic Molecular Weight | 298.179361346 |
|---|
| IUPAC Name | 4-methyl-N-[2-(morpholin-4-yl)ethyl]-6-phenylpyridazin-3-amine |
|---|
| Traditional Name | minaprine |
|---|
| CAS Registry Number | 25905-77-5 |
|---|
| SMILES | CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20) |
|---|
| InChI Key | LDMWSLGGVTVJPG-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenylpyridazines. These are organic compounds containing a pyridazine ring substituted by a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazines |
|---|
| Sub Class | Pyridazines and derivatives |
|---|
| Direct Parent | Phenylpyridazines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenylpyridazine
- Imidolactam
- Benzenoid
- Oxazinane
- Morpholine
- Monocyclic benzene moiety
- Heteroaromatic compound
- Tertiary aliphatic amine
- Tertiary amine
- Oxacycle
- Azacycle
- Ether
- Dialkyl ether
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 122 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.07 g/L | Not Available | | LogP | 2 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.83 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.7367 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.19 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 98.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 558.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 205.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 137.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 174.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 77.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 292.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 351.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 539.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 671.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 102.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 940.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 204.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 269.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 432.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 371.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 119.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Minaprine,1TMS,isomer #1 | CC1=CC(C2=CC=CC=C2)=NN=C1N(CCN1CCOCC1)[Si](C)(C)C | 2616.5 | Semi standard non polar | 33892256 | | Minaprine,1TMS,isomer #1 | CC1=CC(C2=CC=CC=C2)=NN=C1N(CCN1CCOCC1)[Si](C)(C)C | 2652.0 | Standard non polar | 33892256 | | Minaprine,1TMS,isomer #1 | CC1=CC(C2=CC=CC=C2)=NN=C1N(CCN1CCOCC1)[Si](C)(C)C | 3594.1 | Standard polar | 33892256 | | Minaprine,1TBDMS,isomer #1 | CC1=CC(C2=CC=CC=C2)=NN=C1N(CCN1CCOCC1)[Si](C)(C)C(C)(C)C | 2855.8 | Semi standard non polar | 33892256 | | Minaprine,1TBDMS,isomer #1 | CC1=CC(C2=CC=CC=C2)=NN=C1N(CCN1CCOCC1)[Si](C)(C)C(C)(C)C | 2873.0 | Standard non polar | 33892256 | | Minaprine,1TBDMS,isomer #1 | CC1=CC(C2=CC=CC=C2)=NN=C1N(CCN1CCOCC1)[Si](C)(C)C(C)(C)C | 3679.9 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Minaprine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0uds-7950000000-d5d6a90ec878b84d8656 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Minaprine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 10V, Positive-QTOF | splash10-01ot-0390000000-9738c44f8e588388c452 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 20V, Positive-QTOF | splash10-03di-0950000000-d3356e07a972e95a28be | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 40V, Positive-QTOF | splash10-01p9-9700000000-020e74ff7f531306c94d | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 10V, Negative-QTOF | splash10-0002-1390000000-b7b5ed826ec7c0c9a3ff | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 20V, Negative-QTOF | splash10-0007-2930000000-a1817395beedfdf562a7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 40V, Negative-QTOF | splash10-001i-8920000000-d33c0ded2360f772d1e3 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 10V, Positive-QTOF | splash10-0002-0090000000-1601373600bf26db83d2 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 20V, Positive-QTOF | splash10-03dj-0290000000-7b731ca9adbace1a0a22 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 40V, Positive-QTOF | splash10-03di-4960000000-0f1b65982977f12661cc | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 10V, Negative-QTOF | splash10-0002-0090000000-524104d6853e23d834e0 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 20V, Negative-QTOF | splash10-0002-0390000000-bb5d2f3e88efabaf8ff6 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Minaprine 40V, Negative-QTOF | splash10-001j-1930000000-ce10f5b73520e9ca3c16 | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|